Actual Medicinal Product (AMP) Sovaldi 400mg tablets (Gilead Sciences Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Does not require any special storage conditions.
- Provenance
-
This compatibility recommendation is derived from Sovaldi 400mg tablets (Gilead Sciences Ltd).
- Generic
- Sofosbuvir
- Formulation
- Sofosbuvir 400mg tablets
-
Sofosbuvir
-
Sofosbuvir 400mg tablets
-
Sovaldi 400mg tablets (Gilead Sciences Ltd)
-
-